The treatment of Arrhythmia & Eye Health with vitamins

Arrhythmia and Eye Health: Mitamins custom make quality formulas for the treatment of Arrhythmia & Eye Health with vitamins. A Arrhythmia & Eye Health formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Arrhythmia and Eye Health

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Calcium
    100
    mg
    10%
    Magnesium
    50
    mg
    13%
    CoQ-10
    50
    mg
    *
    Omega - 3 Fatty Acids
    50
    mg
    *
    Lutein
    1000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Bioflavonoid Concentrate
    50
    mg
    *
    Garlic Extract
    50
    mg
    *
    Grape Seed Extract
    50
    mg
    *
    Green Tea Extract
    50
    mg
    *
    Hawthorn Extract
    50
    mg
    *
    N-Acetyl L-Cysteine
    100
    mg
    *
    Amino Acid Mix
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Arrhythmia and Eye Health
Monthly Cost: $30.39
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Arrhythmia and Eye Health Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Patient Enrollment On Target In National Institutes Of Health Phase III Parkinson's Disease Trial
Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today that the Phase III efficacy trial of the Company's lead Parkinson's disease drug candidate, PD-02, has enrolled 288 patients in the first three months.
Flu Shots Still Not Reaching Many In High Risk Groups In Canada
Although flu vaccination rates across Canada have gone up, a large number of high-risk people are still not being vaccinated, according to a study carried out by Statistics Canada. After seeming to level off in 2003, vaccination rates across Canada started to increase again in 2005.
This information concerning the support of Arrhythmia and Eye Health treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Heart & Vascular Health  Arrhythmia  Arrhythmia and Eye Health
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments